Intellect Neurosciences
New York
About Intellect Neurosciences
Intellect Neurosciences Inc. is a New York based biopharmaceutical company engaged in the discovery and development of a new breed of innovative “disease-modifying” therapeutic drugs designed to slow, arrest and ultimately prevent Alzheimer's disease and other serious neurological disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2010)
- Ticker: otcpink:ILNS
- Website: intellectns.com
- Phone: (201)608-5101
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/intellect-neurosciences-1193420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.